Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy

Carlos Alberto Dumont1, Lorenzo Monserrat, Jesús Peteiro

  • 1Cardiology Division, Juan Canalejo Hospital, A Coruña, Spain.

Insights

Left ventricular (LV) chamber stiffness, a measure of diastolic dysfunction, significantly impacts exercise capacity in hypertrophic cardiomyopathy (HC) patients. Increased LV stiffness is a key predictor of reduced exercise tolerance in HC.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Biomedical Engineering

Background:

  • Conventional markers inadequately predict exercise capacity in hypertrophic cardiomyopathy (HC).
  • Exercise intolerance in HC is primarily linked to impaired left ventricular (LV) stroke volume augmentation due to diastolic dysfunction.
  • The impact of noninvasively assessed LV chamber stiffness on exercise tolerance in HC remains unclear.

Purpose of the Study:

  • To investigate the relationship between LV chamber stiffness and exercise capacity in patients with HC.
  • To determine if LV chamber stiffness is a significant determinant of maximal exercise tolerance in HC.

Main Methods:

  • Sixty-four HC patients underwent Doppler echocardiography, exercise testing, and cardiac magnetic resonance.
  • LV chamber stiffness index calculated as pulmonary capillary wedge pressure (from E/Ea ratio) divided by LV end-diastolic volume (from CMR).
  • Maximal exercise tolerance measured by achieved METs.

Main Results:

  • Maximal exercise capacity (METs) inversely correlated with age, heart rate deficit, LV outflow tract gradient, E/Ea ratio, LV wall thickness, and LV stiffness.
  • LV stiffness showed the strongest inverse correlation with METs achieved (r = -0.56, p <0.001).
  • Multivariate analysis identified LV chamber stiffness as the sole independent predictor of exercise capacity; a threshold of 0.18 mm Hg/ml predicted METs ≤7 with 100% sensitivity and 75% specificity.

Conclusions:

  • Increased LV chamber stiffness, reflecting resting LV diastolic dysfunction, is a primary determinant of maximal exercise capacity in HC patients.
  • Noninvasive assessment of LV chamber stiffness offers valuable prognostic information regarding exercise tolerance in HC.
  • Targeting LV diastolic dysfunction may improve exercise capacity in hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...